249 related articles for article (PubMed ID: 1452501)
1. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis.
Clemons KV; Stevens DA
J Antimicrob Chemother; 1992 Sep; 30(3):353-63. PubMed ID: 1452501
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1991 Sep; 35(9):1829-33. PubMed ID: 1952853
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.
Clemons KV; Capilla J; Sobel RA; Martinez M; Tong AJ; Stevens DA
Antimicrob Agents Chemother; 2009 May; 53(5):1858-62. PubMed ID: 19273680
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.
González GM; González G; Najvar LK; Graybill JR
J Antimicrob Chemother; 2007 Dec; 60(6):1341-6. PubMed ID: 17934204
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1998 Apr; 42(4):899-902. PubMed ID: 9559804
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
7. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.
Denning DW; Warn P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734
[TBL] [Abstract][Full Text] [Related]
8. Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2004 Jun; 48(6):2140-3. PubMed ID: 15155212
[TBL] [Abstract][Full Text] [Related]
9. Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of murine coccidioidal meningitis.
Allendoerfer R; Yates RR; Sun SH; Graybill JR
J Med Vet Mycol; 1992; 30(5):377-84. PubMed ID: 1469539
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Amphotericin B Lipid Formulations for Treatment of Severe Coccidioidomycosis.
Sidhu R; Lash DB; Heidari A; Natarajan P; Johnson RH
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686150
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B lipid complex.
Rapp RP; Gubbins PO; Evans ME
Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B formulations: a comparative review of efficacy and toxicity.
Hamill RJ
Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
[TBL] [Abstract][Full Text] [Related]
13. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.
Warn PA; Morrissey J; Moore CB; Denning DW
Antimicrob Agents Chemother; 2000 Oct; 44(10):2664-71. PubMed ID: 10991841
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits.
Clemons KV; Sobel RA; Williams PL; Pappagianis D; Stevens DA
Antimicrob Agents Chemother; 2002 Aug; 46(8):2420-6. PubMed ID: 12121913
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis.
Lewis RE; Albert ND; Liao G; Hou J; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2010 Mar; 54(3):1298-304. PubMed ID: 20038620
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis.
Hoeprich PD; Merry JM
Diagn Microbiol Infect Dis; 1987 Apr; 6(4):287-92. PubMed ID: 3581735
[TBL] [Abstract][Full Text] [Related]
19. Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.
Zhang Z; Diener RM; Lipman JM
Int J Toxicol; 2006; 25(4):285-94. PubMed ID: 16815817
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Clemons KV; Schwartz JA; Stevens DA
Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
